These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31771969)

  • 1. Gain-of-Function
    Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
    Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RHOA
    Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
    Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
    Gut; 2024 Jul; 73(8):1280-1291. PubMed ID: 38621923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
    Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
    Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Rho(d) Map to Diffuse Gastric Cancer.
    Benton D; Chernoff J
    Cancer Discov; 2020 Feb; 10(2):182-184. PubMed ID: 32024682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection.
    Del Re DP; Miyamoto S; Brown JH
    J Biol Chem; 2008 Dec; 283(51):35622-9. PubMed ID: 18854312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHOA drivers take alternate routes in gastric cancer.
    Benton D; Chernoff J
    Sci Signal; 2023 Dec; 16(816):eadk9171. PubMed ID: 38113334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro.
    Xu XP; He HL; Hu SL; Han JB; Huang LL; Xu JY; Xie JF; Liu AR; Yang Y; Qiu HB
    Stem Cell Res Ther; 2017 Jul; 8(1):164. PubMed ID: 28697804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer.
    Peng K; Zhang F; Wang Y; Sahgal P; Li T; Zhou J; Liang X; Zhang Y; Sethi N; Liu T; Zhang H; Bass AJ
    Clin Cancer Res; 2023 Jan; 29(1):197-208. PubMed ID: 36278961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
    Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
    Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly.
    Orr AW; Pallero MA; Xiong WC; Murphy-Ullrich JE
    J Biol Chem; 2004 Nov; 279(47):48983-92. PubMed ID: 15371459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.
    Guessous F; Yang Y; Johnson E; Marcinkiewicz L; Smith M; Zhang Y; Kofman A; Schiff D; Christensen J; Abounader R
    Mol Cancer Ther; 2012 Feb; 11(2):288-97. PubMed ID: 22188814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
    Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
    Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
    Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
    Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
    Park JH; Ryu JM; Han HJ
    J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoA/ROCK, cytoskeletal dynamics, and focal adhesion kinase are required for mechanical stretch-induced tenogenic differentiation of human mesenchymal stem cells.
    Xu B; Song G; Ju Y; Li X; Song Y; Watanabe S
    J Cell Physiol; 2012 Jun; 227(6):2722-9. PubMed ID: 21898412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
    Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
    Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
    Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
    J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated microgravity inhibits the viability and migration of glioma via FAK/RhoA/Rock and FAK/Nek2 signaling.
    Deng B; Liu R; Tian X; Han Z; Chen J
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):260-271. PubMed ID: 30820814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.